Effects of IL-22 on cardiovascular diseases
Authors:
- 1 April 2020
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 81, 106277
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81902136, 81871244)
- Science and Technology Planning Social Development Project of Zhenjiang City (SH2018027)
- China Postdoctoral Science Foundation (2019M660106)
This publication has 92 references indexed in Scilit:
- IL-22 exacerbates the severity of CVB3-induced acute viral myocarditis in IL-17A-deficient miceMolecular Medicine Reports, 2013
- Increased Expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditisVirology Journal, 2012
- STAT3 signal transduction through interleukin-22 in oral squamous cell carcinomaInternational Journal of Oncology, 2012
- Expression of il-23/th17 pathway in a murine model of coxsackie virus b3-induced viral myocarditisVirology Journal, 2011
- The ERK Cascade: Distinct Functions within Various Subcellular OrganellesGenes & Cancer, 2011
- γδ T cells protect against lung fibrosis via IL-22Journal of Experimental Medicine, 2010
- New Activation Modus of STAT3Journal of Biological Chemistry, 2009
- Structure of IL-22 Bound to Its High-Affinity IL-22R1 ChainStructure, 2008
- Amelioration of Coxsackievirus B3-Mediated Myocarditis by Inhibition of Tissue Inhibitors of Matrix Metalloproteinase-1The American Journal of Pathology, 2007
- Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicityMethods, 2007